With cancer projected to escalate to 29 million cases by 2040, Novigenix, a pioneer in AI healthcare solutions, is rewriting the rules of cancer care....
Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery, patient engagement, and...
Financing advances development of Prota's peanut allergy remission therapy in preparation for a Phase 3 clinical trial
Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology...
Affecting Drug Development Schedules and Financial Plans
Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis...
Spiden, a pioneer in non-invasive biomarker monitoring technology, is thrilled to announce a significant scientific milestone, key additions to its executive team and an...
Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs
ChemPartner, a global leader in drug discovery and...
